Featured post

Largest real-world data study finds Mounjaro three times more effective than Ozempic for weight loss

In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15% weight loss than those taking semaglutide (Ozempic).

First real-world comparative effectiveness study of Mounjaro and Ozempic